We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$413B
AUM Growth
+$27.3B
Cap. Flow
+$13.5B
Cap. Flow %
3.28%
Top 10 Hldgs %
17.41%
Holding
4,308
New
177
Increased
3,043
Reduced
580
Closed
101

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$511M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$442M
3
MSFT icon
Microsoft
MSFT
+$392M
4
AMZN icon
Amazon
AMZN
+$348M
5
CTVA icon
Corteva
CTVA
+$288M

Sector Composition

Rank Sector Weight
1 Technology 18.3%
2 Financials 15.46%
3 Healthcare 13.81%
4 Consumer Discretionary 10.38%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DK icon
1001
Delek US
DK
$3.72B
$40.5M 0.01%
1,000,482
-51,729
-5% -$1.89M
QTS
1002
DELISTED
QTS REALTY TRUST, INC.
QTS
$40.5M 0.01%
876,129
+73,914
+9% +$3.37M
UTHR icon
1003
United Therapeutics
UTHR
$22.7B
$40.4M 0.01%
517,318
-56,290
-10% -$5.26M
MSM icon
1004
MSC Industrial Direct
MSM
$6.87B
$40.3M 0.01%
542,861
+34,149
+7% +$2.63M
CLGX
1005
DELISTED
Corelogic, Inc.
CLGX
$40.3M 0.01%
963,200
+35,285
+4% +$1.44M
SKYW icon
1006
Skywest
SKYW
$4.18B
$40.2M 0.01%
662,333
+33,627
+5% +$1.99M
ENV
1007
DELISTED
ENVESTNET, INC.
ENV
$40.1M 0.01%
586,849
+52,571
+10% +$3.61M
PGRE
1008
DELISTED
Paramount Group
PGRE
$40.1M 0.01%
2,859,798
+145,058
+5% +$2.09M
ALKS icon
1009
Alkermes
ALKS
$8.29B
$40.1M 0.01%
1,778,041
+158,433
+10% +$4.34M
GMED icon
1010
Globus Medical
GMED
$11.7B
$40M 0.01%
946,425
+76,109
+9% +$3.31M
IOVA icon
1011
Iovance Biotherapeutics
IOVA
$2.9B
$40M 0.01%
1,632,556
+159,148
+11% +$2.4M
WEN icon
1012
Wendy's
WEN
$1.39B
$40M 0.01%
2,043,071
-2,061
-0.1% -$38.8K
OLN icon
1013
Olin
OLN
$2.15B
$40M 0.01%
1,824,525
+30,140
+2% +$671K
DAR icon
1014
Darling Ingredients
DAR
$9.99B
$39.9M 0.01%
2,005,013
+134,028
+7% +$2.75M
NUVA
1015
DELISTED
NuVasive, Inc.
NUVA
$39.9M 0.01%
680,981
+51,845
+8% +$3.06M
FIVN icon
1016
FIVE9
FIVN
$2.58B
$39.8M 0.01%
776,235
+68,625
+10% +$3.48M
HOMB icon
1017
Home BancShares
HOMB
$6.17B
$39.8M 0.01%
2,066,220
+74,867
+4% +$1.39M
ACAD icon
1018
Acadia Pharmaceuticals
ACAD
$5.06B
$39.8M 0.01%
1,487,832
+66,169
+5% +$1.69M
WAFD icon
1019
WaFd
WAFD
$2.76B
$39.7M 0.01%
1,137,727
+130,690
+13% +$4.23M
FOLD
1020
DELISTED
Amicus Therapeutics
FOLD
$39.6M 0.01%
3,176,491
+452,284
+17% +$5.74M
VIAV icon
1021
Viavi Solutions
VIAV
$9.18B
$39.6M 0.01%
2,978,820
+185,694
+7% +$2.4M
EFOR
1022
Everforth Inc
EFOR
$1.33B
$39.6M 0.01%
652,701
+47,276
+8% +$2.84M
SMG icon
1023
ScottsMiracle-Gro
SMG
$3.63B
$39.5M 0.01%
401,485
+2,038
+0.5% +$181K
DOC
1024
DELISTED
PHYSICIANS REALTY TRUST
DOC
$39.5M 0.01%
2,267,181
+181,107
+9% +$3.29M
NEWR
1025
DELISTED
New Relic, Inc.
NEWR
$39.4M 0.01%
455,368
-64,370
-12% -$6.36M

Similar funds

Geode Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Geode Capital Management held 4,308 positions worth $413B, up 7.1% from $386B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management deployed $13.5B of net new capital in Q2 2019, opening 177 new positions and adding to 3,043 existing holdings. Its largest new stake was Dow Inc: 9,682,103 shares worth $477M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $419M trimmed.

  • Geode Capital Management's largest Q2 2019 buy was Dow Inc: 9,682,103 shares worth $477M.
  • Geode Capital Management added most to Alphabet (Google) Class A in Q2 2019, an estimated $442M increase.
  • Geode Capital Management's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $419M.
  • Geode Capital Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $109M.
  • Geode Capital Management's ten largest holdings make up 17% of its $413B portfolio in Q2 2019.
  • Geode Capital Management opened 177 new positions and closed 101 in Q2 2019.
  • Geode Capital Management's portfolio value rose 7.1% quarter-over-quarter to $413B.

Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.